Heparin
Concept
Vocabulary Service
Overview
subject area of
-
10 Anticoagulant therapy in venous thromboembolism Academic Article
-
15 Side-effects of antithrombotic therapy Academic Article
-
4 Clinical potential of low molecular weight heparins Academic Article
-
4Ts scoring with hemofiltration or hemodialysis clotting Academic Article
-
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia Academic Article
-
A 14-year study of heparin-induced thrombocytopenia Academic Article
-
A Comparative Randomized Trial of Low-Dose Versus High-Dose Streptokinase in Deep Vein Thrombosis of the Thigh Academic Article
-
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Academic Article
-
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease Academic Article
-
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation Academic Article
-
A Computer Generated Induction System for Hospitalized Patients Starting on Oral Anticoagulant Therapy Academic Article
-
A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats Academic Article
-
A Histomorphometric Evaluation of Heparin-Induced Bone Loss After Discontinuation of Heparin Treatment in Rats Academic Article
-
A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep Academic Article
-
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Academic Article
-
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism Academic Article
-
A Meta-analysis of the Studies of Dihydroergotamine plus Heparin in the Prophylaxis of Deep Vein Thrombosis Academic Article
-
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial Academic Article
-
A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time Academic Article
-
A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery Academic Article
-
A Systematic Review of Heparin to Treat Burn Injury Academic Article
-
A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia Academic Article
-
A comparison of continuous infusion and intermittent flushing methods in peripheral intravenous catheters in neonates. Academic Article
-
A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparation Academic Article
-
A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo Academic Article
-
A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis Academic Article
-
A diagnostic test for heparin-induced thrombocytopenia Academic Article
-
A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry Academic Article
-
A novel antithrombin-heparin covalent complex Academic Article
-
A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia Academic Article
-
A practical approach to evaluating postoperative thrombocytopenia Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins Academic Article
-
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions Academic Article
-
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin Academic Article
-
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Academic Article
-
A standard heparin nomogram for the management of heparin therapy Academic Article
-
A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism Academic Article
-
A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V Academic Article
-
A unified method for regional anticoagulation of blood. Academic Article
-
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies Academic Article
-
ATENOLOL, HEPARIN AND THE INTERMEDIATE CORONARY SYNDROME Academic Article
-
AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION Academic Article
-
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study Academic Article
-
Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction Academic Article
-
Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Academic Article
-
Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction Academic Article
-
Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium Academic Article
-
Activation of blood coagulation by plaque rupture: Mechanisms and prevention Academic Article
-
Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and d-Phe-Pro-Arg-Ch2Cl Academic Article
-
Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparin Academic Article
-
Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia Academic Article
-
Acute Thrombocytopenia and Thrombosis. Academic Article
-
Acute coronary syndromes: a focus on thrombin. Academic Article
-
Acute intraoperative HIT during heart surgery: Why so rare? Academic Article
-
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation Academic Article
-
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Academic Article
-
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia Academic Article
-
Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis Academic Article
-
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis Academic Article
-
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis Academic Article
-
Adverse outcomes associated with managing suspected heparin induced thrombocytopenia in the critically ill Academic Article
-
Age-related differences in heparin response Academic Article
-
Agents for the Treatment of Heparin-Induced Thrombocytopenia Academic Article
-
Airways Disease Presenting as Restrictive Impairment: Response Academic Article
-
Alpha-2-Macroglobulin Is an Important Progressive Inhibitor of Thrombin in Neonatal and Infant Plasma Academic Article
-
Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children Academic Article
-
Altered inactivation of trinitrophenylated thrombin by antithrombin iii in the presence of heparin Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy Academic Article
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients Academic Article
-
An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition Academic Article
-
An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters Academic Article
-
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients Academic Article
-
An Instrument-based Immunoassay with an Appropriate Normal Range: Minimizing HIT Overdiagnosis Academic Article
-
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction Academic Article
-
An Overview of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
-
An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin‐induced thrombocytopenia Academic Article
-
An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia Academic Article
-
An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators. Academic Article
-
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Academic Article
-
Analysis of Inhibition Rate Enhancement by Covalent Linkage of Antithrombin to Heparin as a Potential Predictor of Reaction Mechanism Academic Article
-
Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients Academic Article
-
Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study Academic Article
-
Analysis of proteins adsorbed to glass from human plasma using immunoblotting methods Academic Article
-
Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay Academic Article
-
Ancrod (Arvin®) as an Alternative to Heparin Anticoagulation for Cardiopulmonary Bypass Academic Article
-
Antemortem Heparin in Organ Donation After Circulatory Death Determination: A Systematic Review of the Literature Academic Article
-
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial Academic Article
-
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia Academic Article
-
Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation Academic Article
-
Anticoagulant Effects of Heparin in Neonatal Plasma' Academic Article
-
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
-
Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls Academic Article
-
Anticoagulant response after dalteparin overdose Academic Article
-
Anticoagulant therapy after acute myocardial infarction Academic Article
-
Anticoagulants During Pregnancy Academic Article
-
Anticoagulants and Their Reversal Academic Article
-
Anticoagulants in Venous Thromboembolism Academic Article
-
Anticoagulants in pregnancy: A review of indications and complications Academic Article
-
Anticoagulation Therapy in Children Academic Article
-
Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis Academic Article
-
Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Anticoagulation for cardiopulmonary bypass: Is a replacement for heparin on the horizon? Academic Article
-
Anticoagulation for patients with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for people with cancer and central venous catheters Academic Article
-
Anticoagulation for perioperative thromboprophylaxis in people with cancer Academic Article
-
Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis Academic Article
-
Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters Academic Article
-
Anticoagulation in venous Thrombosis Academic Article
-
Anticoagulation of Pregnant Women With Mechanical Heart Valves Academic Article
-
Anticoagulation therapy in neonates, children and adolescents Academic Article
-
Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report Academic Article
-
Antiphospholipid and anti‐PF4 antibodies: an association affecting anti‐PF4/heparin assay analysis Academic Article
-
Antiphospholipid antibody syndrome Academic Article
-
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations Academic Article
-
Antithrombin-Heparin Covalent Complex Academic Article
-
Antithrombin-III-Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity Academic Article
-
Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity Academic Article
-
Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model Academic Article
-
Antithrombins: Their Potential as Antithrombotic Agents Academic Article
-
Antithrombotic Agents in Coronary Artery Disease Academic Article
-
Antithrombotic Drugs Academic Article
-
Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis Academic Article
-
Antithrombotic Therapy During Percutaneous Coronary Intervention Academic Article
-
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Antithrombotic Therapy in Children* Academic Article
-
Antithrombotic Therapy in Neonates and Children Academic Article
-
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty Academic Article
-
Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Academic Article
-
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Academic Article
-
Antithrombotic therapy in children with venous thromboembolism Academic Article
-
Antithrombotic therapy in deep vein thrombosis and pulmonary embolism. Academic Article
-
Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis Academic Article
-
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein Academic Article
-
Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis Academic Article
-
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia Academic Article
-
Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines. Academic Article
-
Are heparins anti-neoplastic agents? Academic Article
-
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia Academic Article
-
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia Academic Article
-
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia Academic Article
-
Argatroban as a Heparin Substitute in Cases of Heparin-Induced Thrombocytopenia Academic Article
-
Article Commentary: Heparin and the Peritoneal Membrane Academic Article
-
Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure? Academic Article
-
Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays Academic Article
-
Assessment of antithrombotic drugs ex vivo and in vivo. Academic Article
-
Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery Academic Article
-
Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans. Academic Article
-
Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma Conference Paper
-
Autoimmune heparin‐induced thrombocytopenia Academic Article
-
Autoimmune heparin‐induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin Academic Article
-
B cells, PF4/heparin complexes, and complement Academic Article
-
Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial Academic Article
-
Benefit of Heparin in Central Venous and Pulmonary Artery Catheters Academic Article
-
Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials Academic Article
-
Beta-Thromboglobulin Radioimmunoassay. A Laboratory Characterization and Evaluation Academic Article
-
Beyond Unfractionated Heparin and Warfarin Academic Article
-
Beyond heparin and warfarin: the new generation of anticoagulants Academic Article
-
Binding of Heparin to Metals Academic Article
-
Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin Academic Article
-
Biodistribution of covalent antithrombin-heparin complexes Academic Article
-
Biologic rationale for the therapeutic role of specific antithrombins Academic Article
-
Bivalent Binding to γA/γ′-Fibrin Engages Both Exosites of Thrombin and Protects It from Inhibition by the Antithrombin-Heparin Complex Academic Article
-
Bivalirudin Academic Article
-
Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. Academic Article
-
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study ( Academic Article
-
Bleeding associated with antithrombotic therapy. Academic Article
-
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents Academic Article
-
Blood-compatible biomaterials by surface coating with a novel antithrombin–heparin covalent complex Academic Article
-
By Increasing the Affinity of Heparin for Fibrin, Zn2+ Promotes the Formation of a Ternary Heparin–Thrombin–Fibrin Complex That Protects Thrombin from Inhibition by Antithrombin Academic Article
-
COVID-19 versus HIT hypercoagulability Academic Article
-
Calcium protects pituitary basic fibroblast growth factors from limited proteolysis by co-purifying proteases Academic Article
-
Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? Academic Article
-
Canadian Consensus Conference on Coronary Thrombolysis--1994 update. Academic Article
-
Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner Academic Article
-
Catalysis of Thrombin Inhibition Provides an Index for Estimating the Antithrombotic Potential of Glycosaminoglycans in Rabbits Academic Article
-
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia Academic Article
-
Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia Academic Article
-
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial Academic Article
-
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty Academic Article
-
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies Academic Article
-
Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity Academic Article
-
Characterization of Heparin Aerosols Generated in Jet and Ultrasonic Nebulizers Academic Article
-
Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia Academic Article
-
Chemical–Physical Characterization of Polyurethane Catheters Modified with a Novel Antithrombin-Heparin Covalent Complex Academic Article
-
Chromatography of heparin on Sepharose–lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding Academic Article
-
Chronic performance of polyurethane catheters covalently coated with ATH complex: A rabbit jugular vein model Academic Article
-
Circulating heparin‐like anticoagulants: Case report and review of literature Academic Article
-
Clinical Experience with Anticoagulant Therapy During Pregnancy Academic Article
-
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy Academic Article
-
Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective Academic Article
-
Clinical Use of Low Molecular Weight Heparins and Heparinoids Academic Article
-
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin‐induced thrombocytopenia Academic Article
-
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials Academic Article
-
Clinical factors influencing the sensitivity to warfarin when restarted after surgery Academic Article
-
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis Academic Article
-
Clinical outcomes with unfractionated heparin or low‐molecular‐weight heparin as bridging therapy in patients on long‐term oral anticoagulants: the REGIMEN registry Academic Article
-
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia Academic Article
-
Clinical potential of antithrombotic drugs in coronary syndromes Academic Article
-
Clinical presentation of heparin-induced thrombocytopenia. Academic Article
-
Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin‐induced thrombocytopenia (HIT) Academic Article
-
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. Academic Article
-
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies Academic Article
-
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Academic Article
-
Coagulation Assays Academic Article
-
Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair Academic Article
-
Coagulation and Fibrinolytic Profile of Paediatric Patients Undergoing Cardiopulmonary Bypass Academic Article
-
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study Academic Article
-
Combination of two complementary automated rapid assays for diagnosis of heparin‐induced thrombocytopenia (HIT) Academic Article
-
Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles Academic Article
-
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Academic Article
-
Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay Academic Article
-
Comment: Treatment of Heparin-Induced Thrombocytopenia Academic Article
-
Comparative behavior of thrombin and an inactive derivative, FPR-thrombin, toward the rabbit vascular endothelium. Heparin liberates FPR-thrombin from the endothelium in vivo. Academic Article
-
Comparative effects of heparin and LMW heparin on hemostasis Conference Paper
-
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
-
Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome Academic Article
-
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism Academic Article
-
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction Academic Article
-
Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease Academic Article
-
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia Academic Article
-
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) Academic Article
-
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial Academic Article
-
Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model Academic Article
-
Comparison of the Effects of Heparin and Hirudin on Thrombin Binding to the Normal and the De-Endothelialized Rabbit Aorta In Vitro Academic Article
-
Comparison of the Effects of Two Doses of Recombinant Hirudin Compared With Heparin in Patients With Acute Myocardial Ischemia Without ST Elevation Academic Article
-
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins Academic Article
-
Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models Academic Article
-
Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism. Academic Article
-
Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits Academic Article
-
Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-iii affinity heparin fraction Academic Article
-
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Academic Article
-
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis. Academic Article
-
Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients Academic Article
-
Complement and the antiphospholipid syndrome Academic Article
-
Complex formation of platelet thrombospondin with histidine-rich glycoprotein. Academic Article
-
Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies – distinguishing "signal" from "noise" Academic Article
-
Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes Academic Article
-
Contaminated Heparin Academic Article
-
Continuing Challenges of Sepsis Research Academic Article
-
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis Academic Article
-
Contribution of Red Blood Cells to the Saturable Mechanism of Heparin Clearance Academic Article
-
Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery Academic Article
-
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients Academic Article
-
Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Academic Article
-
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis Academic Article
-
Covalent Antithrombin-Heparin Complexes with High Anticoagulant Activity Academic Article
-
Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes Academic Article
-
Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va Academic Article
-
Covalent antithrombin–heparin complexes Academic Article
-
Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets Academic Article
-
Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
-
D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism Academic Article
-
DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE Academic Article
-
Dalteparin and Heparin-Induced Thrombocytopenia Academic Article
-
Dalteparin versus Unfractionated Heparin in Critically Ill Patients Academic Article
-
Dealing with Drug-Induced Thrombocytopenia Academic Article
-
Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential Academic Article
-
Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass Academic Article
-
Deep Vein Thrombosis and Its Prevention in Critically Ill Adults Academic Article
-
Deep Vein Thrombosis: Recovery or Recurrence? Academic Article
-
Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients. Academic Article
-
Deep venous thrombosis in the medically ill. Academic Article
-
Defining the heparin-binding domain of antithrombin Academic Article
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin Academic Article
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis Academic Article
-
Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin “flushes” Academic Article
-
Demand on-demand testing for the diagnosis of heparin-induced thrombocytopenia Academic Article
-
Dermatan sulphate in heparin-induced thrombocytopenia Academic Article
-
Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy Academic Article
-
Design of the rivaroxaban for heparin-induced thrombocytopenia study Academic Article
-
Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial Academic Article
-
Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. Academic Article
-
Development of a high-yield expression and purification system for platelet factor 4 Academic Article
-
Device Surgery without Interruption of Anticoagulation Academic Article
-
Device surgery without interruption of anticoagulation. Academic Article
-
Diagnosis of Heparin-induced Thrombocytopenia:Still a Journey, Not Yet a Destination Academic Article
-
Diagnosis of thrombosis. Evaluation of 125I-fibrinogen scanning and blood tests. Academic Article
-
Diagnostic accuracy of IgG‐specific versus polyspecific enzyme‐linked immunoassays in heparin‐induced thrombocytopenia: a systematic review and meta‐analysis Academic Article
-
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis Academic Article
-
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review Academic Article
-
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin Conference Paper
-
Direct thrombin inhibitors in acute coronary syndromes Academic Article
-
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary intervention Academic Article
-
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data Academic Article
-
Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction Academic Article
-
Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia Academic Article
-
Dosing Frequency of Unfractionated Heparin Thromboprophylaxis Academic Article
-
Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis Academic Article
-
Drug-Induced Platelet Destruction Academic Article
-
EFFECT OF SERA ON THROMBIN ACTIVATION RATE CONSTANTS: A ONE-STAGE ASSAY OF THE EXTRINSIC SYSTEM Academic Article
-
EVALUATION OF SUBCUTANEOUS CALCIUM HEPARIN THERAPY IN THE TREATMENT OF THROMBO‐EMBOLIC DISEASE Academic Article
-
EXPERIMENTAL PRODUCTION OF MICROANGIOPATHIC HÆMOLYTIC ANÆMIA IN VIVO Academic Article
-
Early rate of resolution of major pulmonary embolism. A study of angiographic and haemodynamic changes occurring in the first 24 to 48 hours. Academic Article
-
Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive Academic Article
-
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. Academic Article
-
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial Academic Article
-
Effect of Heparin Loading During Congenital Heart Operation on Thrombin Generation and Blood Loss Academic Article
-
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
-
Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin Academic Article
-
Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium Academic Article
-
Effect of anti‐platelet factor‐4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery Academic Article
-
Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung Academic Article
-
Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor Academic Article
-
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin Academic Article
-
Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA. Academic Article
-
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro Academic Article
-
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography Academic Article
-
Effectiveness of Anticoagulants Academic Article
-
Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo Academic Article
-
Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli Academic Article
-
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits Academic Article
-
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Academic Article
-
Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III Academic Article
-
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth Academic Article
-
Effects of high fat provision on muscle PDH activation and malonyl-CoA content in moderate exercise Academic Article
-
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina Academic Article
-
Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial Academic Article
-
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty Academic Article
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Academic Article
-
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients Academic Article
-
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 Academic Article
-
Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement Academic Article
-
Efficacy and safety of enoxaparin versus
unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment Academic Article
-
Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis Academic Article
-
End of the road for heparin thromboprophylaxis Academic Article
-
Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles Academic Article
-
Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin. Academic Article
-
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction Academic Article
-
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Academic Article
-
Erythrocyte insulin receptors remain intact through three days of storage Academic Article
-
Establishing a Therapeutic Range for Heparin Therapy Academic Article
-
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Academic Article
-
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings Academic Article
-
Evidence and clinical judgment: Treatment of cerebral vein thrombosis Academic Article
-
Evidence for a saturable mechanism of disappearance of standard heparin in rabbits Academic Article
-
Evidence that Rabbit <sup>125</sup>I-Antithrombin III Binds to Proteoheparan Sulphate at the Subendothelium of the Rabbit Aorta in vitro Academic Article
-
Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis Academic Article
-
Evidence-Based Management of Anticoagulant Therapy Academic Article
-
Evidence-based treatment of the antiphospholipid syndrome Academic Article
-
Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin Academic Article
-
Executive Summary Academic Article
-
Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II Academic Article
-
Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin Academic Article
-
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study Academic Article
-
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy? Academic Article
-
Factor V Leiden and Thrombotic Complications in Heparin-induced Thrombocytopenia Academic Article
-
Factors responsible for ADP-induced release reaction of human platelets Article
-
Factors responsible for target site selection in Tn10 transposition: a role for the DDE motif in target DNA capture Academic Article
-
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists Academic Article
-
Fatal heparin‐induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of ‘spontaneous’ HIT? Academic Article
-
Fate of Thrombin and Thrombin-Antithrombin-III Complex Adsorbed to a Heparinized Biomaterial: Analysis of the Enzyme-Inhibitor Complexes Displaced by Plasma Academic Article
-
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia Academic Article
-
Feasibility of Using Recombinant Factor VIIa in Continuous Infusion Academic Article
-
Fetal and neonatal outcome of exposure to anticoagulants during pregnancy Academic Article
-
Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Academic Article
-
Fibrinogen Catabolism in Microangiopathic Haemolytic Anaemia Academic Article
-
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT Academic Article
-
Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban Academic Article
-
Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia Academic Article
-
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study Academic Article
-
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke Academic Article
-
Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series Academic Article
-
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin Academic Article
-
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux Academic Article
-
Fondaparinux: does it cause HIT? can it treat HIT? Academic Article
-
Formation of anti–platelet factor 4/heparin antibodies after cardiac surgery: Influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status Academic Article
-
Frequency of Heparin-Induced Thrombocytopenia in Critical Care Patients Academic Article
-
From unfractionated heparins to low molecular weight heparins. Academic Article
-
Further complexities in diagnosing acquired thrombocytopenia: unexpected parallels between antibody-mediated delayed thrombocytopenia with abciximab and heparin induced thrombocytopenia Academic Article
-
Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia Academic Article
-
Generic Bioaffinity Silicone Surfaces Academic Article
-
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia Academic Article
-
Glycosaminoglycans Bind Factor Xa in a Ca2+-Dependent Fashion and Modulate Its Catalytic Activity Academic Article
-
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group. Academic Article
-
Guide to Anticoagulant Therapy: Heparin Academic Article
-
Guide to Anticoagulant Therapy: Heparin Academic Article
-
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. Academic Article
-
HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS Academic Article
-
HEPARIN TREATMENT OF HAEMOLYSIS AND THROMBOCYTOPENIA IN PRE-ECLAMPSIA. Report of a Case and a Review of the Literature Academic Article
-
HIT paradigms and paradoxes Academic Article
-
HIT: Lessons Learned Conference Paper
-
HITlights: A career perspective on heparin-induced thrombocytopenia Academic Article
-
Hemodialysis-Associated Acute Systemic Reactions and Heparin-Induced Thrombocytopenia Academic Article
-
Hemorrhagic Complications of Anticoagulant Therapy Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
-
Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated? Academic Article
-
Hemorrhagic complications of anticoagulant treatment. Academic Article
-
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Academic Article
-
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Academic Article
-
Heparin Academic Article
-
Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance Academic Article
-
Heparin Brand Is Associated With Postsurgical Outcomes in Children Undergoing Cardiac Surgery Academic Article
-
Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Academic Article
-
Heparin Dependent Coiled‐Coil Formation Academic Article
-
Heparin Effect on Bone Density Academic Article
-
Heparin Improves Gas Exchange during Experimental Acute Lung Injury in Newborn Piglets Academic Article
-
Heparin Inhibits Melatonin Binding and Signal Transduction in Chick Brain Academic Article
-
Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway Academic Article
-
Heparin Therapy in Venous Thromboembolism Academic Article
-
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Academic Article
-
Heparin Treatment of Haemolytic Anæmia and Thrombocytopenia in Pre-Eclampsia Academic Article
-
Heparin and Angiogenesis Academic Article
-
Heparin and Graduated Compression Stockings in Patients Academic Article
-
Heparin and Low Molecular Weight Heparins Inhibit Prothrombinase Formation but not its Activity in Plasma Academic Article
-
Heparin and Low-Molecular-Weight Heparin Academic Article
-
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Academic Article
-
Heparin and Platelets Academic Article
-
Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases Academic Article
-
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction Academic Article
-
Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass. Academic Article
-
Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein Academic Article
-
Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far? Academic Article
-
Heparin clearance and ex vivo recovery in newborn piglets and adult pigs Academic Article
-
Heparin compromises streptokinase-induced arterial patency in rabbits Academic Article
-
Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells Academic Article
-
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis Academic Article
-
Heparin for Mural Thrombosis in Anterior Myocardial Infarction Academic Article
-
Heparin for Proximal-Vein Thrombosis Academic Article
-
Heparin for prolonging peripheral intravenous catheter use in neonates Academic Article
-
Heparin in the Treatment of Thromboembolic Stroke Academic Article
-
Heparin induced bleeding. Academic Article
-
Heparin induced thrombocytopenia Academic Article
-
Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium. Academic Article
-
Heparin kinetics in venous thrombosis and pulmonary embolism. Academic Article
-
Heparin or nonheparin anticoagulants for VITT Academic Article
-
Heparin resistance in acute coronary syndromes Academic Article
-
Heparin sensitivity and resistance in the neonate: An explanation Academic Article
-
Heparin therapy during pregnancy. Risks to the fetus and mother Academic Article
-
Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns Academic Article
-
Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma Academic Article
-
Heparin, DDAVP and the Bleeding Time Academic Article
-
Heparin-Associated Thrombocytopenia Academic Article
-
Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Academic Article
-
Heparin-Induced Thrombocytopenia Associated with Fondaparinux Academic Article
-
Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages Academic Article
-
Heparin-Induced Thrombocytopenia and Vascular Surgery Academic Article
-
Heparin-Induced Thrombocytopenia in Critically Ill Patients Academic Article
-
Heparin-Induced Thrombocytopenia in Critically Ill Patients Academic Article
-
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin Academic Article
-
Heparin-Induced Thrombocytopenia in Patients with Ventricular Assist Devices: Are New Prevention Strategies Required? Academic Article
-
Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing Academic Article
-
Heparin-Induced Thrombocytopenia in the ICU Academic Article
-
Heparin-Induced Thrombocytopenia: A Clinicopathologic Syndrome Academic Article
-
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
-
Heparin-Induced Thrombocytopenia: An Iceberg Rising Academic Article
-
Heparin-Induced Thrombocytopenia: Real-World Issues Academic Article
-
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention Academic Article
-
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia Academic Article
-
Heparin-binding serum protein(s) is required for the protection of sialyltransferase released during the incubation of rat jejunal slices Academic Article
-
Heparin-induced Thrombocytopenia Academic Article
-
Heparin-induced Thrombocytopenia: Towards Consensus Academic Article
-
Heparin-induced Thrombocytopenia: Yet Another Treatment Paradox? Academic Article
-
Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes Academic Article
-
Heparin-induced skin necrosis Academic Article
-
Heparin-induced thrombocytopenia Academic Article
-
Heparin-induced thrombocytopenia Academic Article
-
Heparin-induced thrombocytopenia and cardiac surgery Academic Article
-
Heparin-induced thrombocytopenia and cardiac surgery Academic Article
-
Heparin-induced thrombocytopenia and its treatment. Conference Paper
-
Heparin-induced thrombocytopenia and the anesthesiologist. Academic Article
-
Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies Academic Article
-
Heparin-induced thrombocytopenia in 2017 and beyond Academic Article
-
Heparin-induced thrombocytopenia in intensive care patients Academic Article
-
Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass Academic Article
-
Heparin-induced thrombocytopenia in renal failure. Academic Article
-
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
-
Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial Academic Article
-
Heparin-induced thrombocytopenia. Academic Article
-
Heparin-induced thrombocytopenia. Conference Paper
-
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Academic Article
-
Heparin-induced thrombocytopenia: What the serologists have taught us Academic Article
-
Heparin-induced thrombocytopenia: a historical perspective Academic Article
-
Heparin-induced thrombocytopenia: an overview Academic Article
-
Heparin-induced thrombocytopenia: laboratory studies Academic Article
-
Heparin-induced thrombocytopenia: pathogenesis and management Academic Article
-
Heparin-induced thrombocytopenia: pathogenesis and management Academic Article
-
Heparin-induced thrombocytopenia: patient profiles and clinical manifestations. Academic Article
-
Heparin-induced thrombosis without thrombocytopenia Academic Article
-
Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2) Academic Article
-
Heparin-modified dendrimer crosslinked collagen matrices for the delivery of heparin-binding epidermal growth factor Academic Article
-
Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS Academic Article
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
-
Heparin‐induced skin lesions Academic Article
-
Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HIT Academic Article
-
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Academic Article
-
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes Academic Article
-
Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests Academic Article
-
Heparin‐induced thrombocytopenia‐associated thrombosis: from arterial to venous to venous limb gangrene Academic Article
-
High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT Academic Article
-
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review Academic Article
-
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome Academic Article
-
Hirudin causes more bleeding than heparin in a rabbit ear bleeding model Academic Article
-
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo Academic Article
-
How I Diagnose and Manage HIT Academic Article
-
How I treat patients with a history of heparin-induced thrombocytopenia Academic Article
-
How can we reduce disagreement among guidelines for venous thromboembolism prevention? Academic Article
-
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice Academic Article
-
How to use unfractionated heparin to treat neonatal thrombosis in clinical practice Academic Article
-
Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. Academic Article
-
Hypercoagulable States Academic Article
-
Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients Academic Article
-
Hypersulfated Low Molecular Weight Heparin with Reduced Affinity for Antithrombin Acts as an Anticoagulant by Inhibiting Intrinsic Tenase and Prothrombinase Academic Article
-
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction Academic Article
-
ISTH guidelines for antithrombotic treatment in COVID‐19 Academic Article
-
Identification of apolipoprotein A-I as a major adsorbate on biomaterial surfaces after blood or plasma contact Academic Article
-
Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma Academic Article
-
Idiosyncratic Drug-Induced Thrombocytopenia1 Academic Article
-
Idiosyncratic Drug-Induced Thrombocytopenia1 Academic Article
-
Immobilization of an antithrombin–heparin complex on gold: Anticoagulant properties and platelet interactions Academic Article
-
Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer Academic Article
-
Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin Academic Article
-
Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies Academic Article
-
Immunoassays are not created equal Academic Article
-
Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Academic Article
-
Immunospecific analysis of in vitro and ex vivo surface-immobilized protein complex Academic Article
-
Impact of Switching Sample Types for High-Sensitivity Cardiac Troponin I Assays in the 0/1 Hour Algorithms Academic Article
-
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Academic Article
-
Impact of the patient population on the risk for heparin-induced thrombocytopenia Academic Article
-
Importance of the spatial display of charged residues in heparinâpeptide interactions Academic Article
-
Improved Bovine ICSI Outcomes by Sperm Selected after Combined Heparin-Glutathione Treatment Academic Article
-
Improving Clinical Interpretation of the Anti-Platelet Factor 4/Heparin Enzyme-Linked Immunosorbent Assay for the Diagnosis of Heparin-Induced Thrombocytopenia Through the Use of Receiver Operating Characteristic Analysis, Stratum-Specific Likelihood Ratios, and Bayes Theorem Academic Article
-
In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke. Academic Article
-
In the Presence of Phospholipids, Glycosaminoglycans Potentiate Factor Xa-Mediated Protein C Activation by Modulating Factor Xa Activity Academic Article
-
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Academic Article
-
In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding Academic Article
-
In vivo activity of a new heparinoid. Academic Article
-
In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex Academic Article
-
Inactivation of thrombin by antithrombin III on a heparinized biomaterial Academic Article
-
Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism Academic Article
-
Incidence and clinical relevance of anti–platelet factor 4/heparin antibodies before cardiac surgery Academic Article
-
Increased heparin clearance in experimental pulmonary embolism. Academic Article
-
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex Academic Article
-
Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma Academic Article
-
Inhibition of Fibrin-Bound Thrombin by a Covalent Antithrombin-Heparin Complex Academic Article
-
Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma Academic Article
-
Inhibition of osteolytic bone metastasis by unfractionated heparin Academic Article
-
Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin–heparin complex Academic Article
-
Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes. Academic Article
-
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction Academic Article
-
Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex Academic Article
-
Initial Experience With Viabahn VBX as the Bridging Stent Graft for Branched and Fenestrated Endovascular Aneurysm Repair Academic Article
-
Intensive Initial Oral Anticoagulation and Shorter Heparin Treatment in Deep Vein Thrombosis Academic Article
-
Interaction of histidine-rich glycoprotein with human T lymphocytes Academic Article
-
Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin Academic Article
-
Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system Academic Article
-
Interactions of polylysine with platelets Article
-
Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys Academic Article
-
Intracardiac shunt with hypoxemia caused by right ventricular dysfunction following pericardiocentesis Academic Article
-
Intraoperative Heparin Flushes and Subsequent Acute Heparin-induced Thrombocytopenia Academic Article
-
Intraoperative anticoagulation and limb amputations in patients with immune heparin‐induced thrombocytopenia who require vascular surgery Academic Article
-
Intravascular Haemolysis with Experimentally Produced Vascular Thrombi Academic Article
-
Intravascular Targeting of a New Anticoagulant Heparin Compound Academic Article
-
Intravascular coagulation in a case of Clostridium perfringens septicaemia: treatment by exchange transfusion and heparin. Academic Article
-
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia Academic Article
-
Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Academic Article
-
Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopenia Academic Article
-
Investigation of the Anticoagulant Mechanisms of a Covalent Antithrombin-Heparin Complex Academic Article
-
Investigations of the effectiveness of heparin variants as inhibitors of histones Academic Article
-
Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice Academic Article
-
Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis? Academic Article
-
Isoform composition of antithrombin in a covalent antithrombin–heparin complex Academic Article
-
Laboratory diagnosis of heparin‐induced thrombocytopenia Academic Article
-
Laboratory diagnosis of immune heparin-induced thrombocytopenia. Academic Article
-
Laboratory testing for VITT antibodies Academic Article
-
Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: A survey of North American specialized coagulation laboratories Academic Article
-
Laboratory testing for heparin-induced thrombocytopenia. Academic Article
-
Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis Academic Article
-
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need? Academic Article
-
Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition Academic Article
-
Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of Antithrombin Academic Article
-
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
-
Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia Academic Article
-
Localization of heparin and low-molecular-weight heparin in the rat kidney Academic Article
-
Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation? Conference Paper
-
Long-term Sequelae of Calf Vein Thrombosis Treated with Heparin or Low-dose Streptokinase Academic Article
-
Looking forward in the treatment of deep-vein thrombosis Academic Article
-
Low Molecular Weight Heparin Academic Article
-
Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
-
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Conference Paper
-
Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials. Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
-
Low molecular weight heparin: laboratory properties and clinical evaluation. A review. Academic Article
-
Low molecular weight heparins and heparinoids Academic Article
-
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial Academic Article
-
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism Academic Article
-
Low-Molecular-Weight Heparin and Deep-Vein Thrombosis Academic Article
-
Low-Molecular-Weight Heparin for Pulmonary Embolism Academic Article
-
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism Academic Article
-
Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease Academic Article
-
Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis Academic Article
-
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery Academic Article
-
Low-molecular-weight heparin for the treatment of venous thromboembolism. Academic Article
-
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis Academic Article
-
Low-molecular-weight heparin: from the bench to the orthopedic patient. Academic Article
-
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis Academic Article
-
Lung Deposition and Clearance of Inhaled 99mTc-Heparin in Healthy Volunteers Academic Article
-
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study Academic Article
-
Management Of Venous Thromboembolism: Optimization By Clinical Trials Academic Article
-
Management of Anticoagulation before and after Elective Surgery Academic Article
-
Management of Deep Vein Thrombosis and Pulmonary Embolism Academic Article
-
Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III Academic Article
-
Management of heparin-induced thrombocytopenia Academic Article
-
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban Academic Article
-
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses Academic Article
-
Management of iliofemoral thrombosis in a pregnant patient with heparin resistance Academic Article
-
Management of unstable angina and myocardial infarction Academic Article
-
Maximum 24‐hour platelet count fall: Metric for improving the diagnosis of heparin‐induced thrombocytopenia among patients with intermediate probability 4Ts scores Academic Article
-
Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin Therapy Academic Article
-
Mechanism of Action and Monitoring of Anticoagulants Academic Article
-
Mechanism of Action and Pharmacology of Unfractionated Heparin Academic Article
-
Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or Pentasaccharide Academic Article
-
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo Academic Article
-
Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex Academic Article
-
Mechanisms Responsible for Catalysis of the Inhibition of Factor Xa or Thrombin by Antithrombin Using a Covalent Antithrombin-Heparin Complex Academic Article
-
Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides Academic Article
-
Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism Academic Article
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Academic Article
-
Mechanisms of Action of Heparin: Applications to the Development of Derivatives of Heparin and Heparinoids with Antithrombotic Properties Academic Article
-
Mechanistic Studies of DNase I Activity: Impact of Heparin Variants and PAD4 Academic Article
-
Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention Academic Article
-
Meta-Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study Academic Article
-
Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention Academic Article
-
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
-
Microangiopathic Haemolytic Anaemia (MHA) Academic Article
-
Microangiopathic Haemolytic Anaemia: The Occurrence of Haemolysis in Experimentally Produced Vascular Disease Academic Article
-
Microangiopathic Haemolytic Anaemia: the Experimental Production of Haemolysis and Red-Cell Fragmentation by Defibrination in Vivo Academic Article
-
Microangiopathic Hemolytic Anemia Academic Article
-
Microheterogeneity of antithrombin III Academic Article
-
Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study* Academic Article
-
Mixing study to diagnose heparin‐resistance caused by functional antithrombin deficiency Academic Article
-
Modification of Polyurethane Surface with an Antithrombin–Heparin Complex for Blood Contact: Influence of Molecular Weight of Polyethylene Oxide Used as a Linker/Spacer Academic Article
-
Modulation of the Enzymatic Activity of α-Thrombin by Polyanions: Consequences on Intrinsic Activation of Factor V and Factor VIII Academic Article
-
Molecular Basis for the Resistance of Fibrin-Bound Thrombin to Inactivation by Heparin/Serpin Complexes Academic Article
-
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin Academic Article
-
Molecular cloning and expression of rabbit antithrombin III Academic Article
-
Monitoring Heparin Therapy Academic Article
-
Monitoring unfractionated heparin with the aPTT: Time for a fresh look Academic Article
-
More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT Academic Article
-
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia Academic Article
-
Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology Academic Article
-
Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids Academic Article
-
Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor Academic Article
-
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia Academic Article
-
Natural, not immune; classical, not alternative Academic Article
-
Navigating the anticoagulant landscape in 2017 Academic Article
-
Neutralization of Heparin Activity Academic Article
-
Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia Academic Article
-
New Anticoagulants Academic Article
-
New Antithrombotic Drugs: Beyond Aspirin and Heparin Academic Article
-
New Approaches for Deep Vein Thrombosis Occurring After Surgery Academic Article
-
New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Academic Article
-
New anticoagulant strategies. Academic Article
-
New developments in anticoagulants: Past, present and future Academic Article
-
Newer Anticoagulants in Critically Ill Patients Academic Article
-
Newer Strategies for the Treatment of Heparin-Induced Thrombocytopenia Academic Article
-
No significant improvement in diagnostic specificity of an anti‐PF4/polyanion immunoassay with use of high heparin confirmatory procedure Academic Article
-
Non-biological factors in day to day variation of heparin requirements. Academic Article
-
Nonhemorrhagic Complications of Anticoagulant Therapy Academic Article
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
-
Nonleg Venous Thrombosis in Critically Ill Adults Conference Paper
-
Non‐necrotizing heparin‐induced skin lesions and the 4T’s score Academic Article
-
Novel anticoagulant agents: introduction Academic Article
-
Observations in anticoagulant and thrombolytic therapy in pulmonary embolism Academic Article
-
Off-pump coronary artery bypass grafting for acute heparin-induced thrombocytopenia Academic Article
-
On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro Academic Article
-
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits Academic Article
-
Optical Densities Reduce Odds of Heparin-induced Thrombocytopenia Over-diagnosis Academic Article
-
Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis Academic Article
-
Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis Academic Article
-
Optimal therapeutic level of heparin therapy in patients with venous thrombosis Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients Academic Article
-
Orthotopic liver transplantation in a patient with combined hemophilia A and B Academic Article
-
Otamixaban in acute coronary syndromes Academic Article
-
Overview of low molecular weight heparins and heparinoids: basic and clinical aspects. Academic Article
-
PATHOPHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA Academic Article
-
PF4‐dependent immunoassays and inferential detection of HIT antibodies Academic Article
-
PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan Academic Article
-
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation Academic Article
-
Pancreatic pseudocyst: heparin-induced haemorrhage through the ampulla of Vater. Academic Article
-
Parenteral Anticoagulants Academic Article
-
Parenteral Anticoagulants Academic Article
-
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
-
Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides Academic Article
-
Performance characteristics of a rapid assay for anti‐PF4/heparin antibodies: the particle immunofiltration assay Academic Article
-
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopenia Academic Article
-
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry) Academic Article
-
Perioperative Management of Antithrombotic Therapy Academic Article
-
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide Academic Article
-
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Academic Article
-
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Academic Article
-
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Academic Article
-
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants Academic Article
-
Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: A retrospective chart review Academic Article
-
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery Academic Article
-
Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis Academic Article
-
Pharmacologic tools to reduce bleeding in surgery. Academic Article
-
Pharmacological Actions of Sulodexide Academic Article
-
Pharmacology of the low-molecular-weight heparins Academic Article
-
Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery Academic Article
-
Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis Academic Article
-
Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass Academic Article
-
Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory Academic Article
-
Placental transport of low molecular weight heparin in the pregnant sheep Academic Article
-
Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfate Academic Article
-
Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications Academic Article
-
Plasma betathromboglobulin and serum fragment E in acute partial stroke Academic Article
-
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities Academic Article
-
Plasma fibrinopeptide A levels in symptomatic venous thromboembolism Academic Article
-
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor. Academic Article
-
Platelet Activation Testing for Heparin-Induced Thrombocytopenia Antibodies Academic Article
-
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia Academic Article
-
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia Academic Article
-
Platelet Interactions with the Endothelium and the Subendothelium: the Role of Thrombin and Prostacyclin Academic Article
-
Platelet Microparticle Generation Assay for Detection of HIT Antibodies: Advance, Retreat, or Too Soon to Tell? Academic Article
-
Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review Academic Article
-
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. Academic Article
-
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay Academic Article
-
Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome Academic Article
-
Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy Academic Article
-
Platelet-activating anti-PF4 disorders: An overview Academic Article
-
Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia Academic Article
-
Polypeptide-Polysaccharide Conjugates Produced by Spontaneous Non-Enzymatic Glycation Academic Article
-
Polyphosphate binds with high affinity to exosite II of thrombin Academic Article
-
Polyurethane modified with an antithrombin-heparin complex via polyethylene oxide linker/spacers: Influence of PEO molecular weight and PEO-ATH bond on catalytic and direct anticoagulant functions Academic Article
-
Pork or beef? Academic Article
-
Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey. Academic Article
-
Pre-operative Plasma Levels of Thrombin-Antithrombin III Complexes Correlate with the Development of Venous Thrombosis after Major Hip or Knee Surgery Academic Article
-
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis Academic Article
-
Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition Academic Article
-
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA) Academic Article
-
Pregnancy, Heparin and Osteoporosis Academic Article
-
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery Academic Article
-
Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatography Academic Article
-
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE Academic Article
-
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study Academic Article
-
Preventing Venous Thromboembolism in Critically Ill Patients Academic Article
-
Prevention and treatment of venous thromboembolism in the elderly patient. Academic Article
-
Prevention of Deep Vein Thrombosis after Elective Hip Surgery Academic Article
-
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator Academic Article
-
Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin Academic Article
-
Prevention of Thrombus Growth by Antithrombin III-Dependent and Two Direct Thrombin Inhibitors in Rabbits: Implications for Antithrombotic Therapy Academic Article
-
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
-
Prevention of Venous Thromboembolism Academic Article
-
Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin Academic Article
-
Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449] Academic Article
-
Prevention of deep venous thrombosis. Academic Article
-
Prevention of left ventricular mural thrombus Academic Article
-
Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: Importance of heparin cofactor II Academic Article
-
Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study Academic Article
-
Prevention of venous thrombosis with small, subcutaneous doses of heparin Academic Article
-
Principles and practice of coronary thrombolysis and conjunctive treatment Academic Article
-
Proceedings: Efficacy and monitoring of heparin therapy in experimental venous thrombosis. Academic Article
-
Proceedings: Heparin kinetics in venous thrombosis and pulmonary embolism. Academic Article
-
Proceedings: The role of heparin on the inhibition of platelet adhesion to damaged arterial endothelial surface Article
-
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism Academic Article
-
Prognostic Significance of Thrombocytopenia During Hirudin and Heparin Therapy in Acute Coronary Syndrome Without ST Elevation Academic Article
-
Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery Academic Article
-
Progressive thrombocytopenia after cardiac surgery in a 67-year-old man Academic Article
-
Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite “Therapeutic” Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding Academic Article
-
Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII Academic Article
-
Prophylactic doses of enoxaparin and heparin inhibit prothrombin activation. Academic Article
-
Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation Academic Article
-
Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent Academic Article
-
Prophylaxis and Therapy of Venous Thromboembolism Academic Article
-
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study Academic Article
-
Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
-
Prophylaxis of venous thromboembolism. An overview. Academic Article
-
Pros and cons of catheter lock solutions Academic Article
-
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia Academic Article
-
Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients Academic Article
-
Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies Academic Article
-
Protamine Requirements in Cardiac Surgery: Effect of Changes in the Heparin Reference Standard Academic Article
-
Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex Academic Article
-
Prothrombotic genetic risk factors and heparin-induced thrombocytopenia Academic Article
-
Pulmonary Embolism in the Elderly Academic Article
-
Pulmonary hypertension and pregnancy: a series of eight cases Academic Article
-
Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions. Academic Article
-
Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays Academic Article
-
Questioning the Treatment of Venous Thromboembolism Academic Article
-
RESOLUTION OF ACUTE MASSIVE PULMONARY EMBOLISM AFTER PULMONARY ARTERIAL INFUSION OF STREPTOKINASE Academic Article
-
Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: Results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis) Academic Article
-
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. Academic Article
-
Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study Academic Article
-
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52. Academic Article
-
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Academic Article
-
Randomized, Controlled Trial of Individualized Heparin and Protamine Management in Infants Undergoing Cardiac Surgery With Cardiopulmonary Bypass Academic Article
-
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments] Academic Article
-
Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Academic Article
-
Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis Academic Article
-
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial Academic Article
-
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. Academic Article
-
Reading between the (Guidelines). Management of submassive pulmonary embolism in the first trimester of pregnancy Academic Article
-
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update Academic Article
-
Recurrent Venous Thrombosis and Heparin Therapy Academic Article
-
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial Academic Article
-
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin Academic Article
-
Relationship Between Dose, Anticoagulant Effect and the Clinical Efficacy and Safety of Heparin Conference Paper
-
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Academic Article
-
Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis Academic Article
-
Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin Academic Article
-
Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin Academic Article
-
Renal venous thrombosis in a newborn with prothrombotic risk factors Academic Article
-
Requirement of Lysine Residues Outside of the Proposed Pentasaccharide Binding Region for High Affinity Heparin Binding and Activation of Human Antithrombin III Academic Article
-
Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens Academic Article
-
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides Academic Article
-
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s Academic Article
-
Reversing Anticoagulant Therapy Academic Article
-
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Academic Article
-
Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism Academic Article
-
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis Academic Article
-
Risks to the Fetus of Anticoagulant Therapy During Pregnancy Academic Article
-
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography Academic Article
-
Rivaroxaban for treatment of HIT: A riveting first experience Academic Article
-
Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study Academic Article
-
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia Academic Article
-
Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model. Academic Article
-
Safe bridging to warfarin in heparin-induced thrombocytopenia Academic Article
-
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study Academic Article
-
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism Academic Article
-
Sample matrix and high-sensitivity cardiac troponin I assays Academic Article
-
Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now? Academic Article
-
Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity Academic Article
-
Senescent human neutrophil binding to thrombospondin (TSP): evidence for a TSP‐independent pathway of phagocytosis by macrophages Academic Article
-
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia Academic Article
-
Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin Academic Article
-
Serotonin‐release assay‐negative heparin‐induced thrombocytopenia Academic Article
-
Serotonin‐release assay‐positive but platelet factor 4‐dependent enzyme‐immunoassay negative:
HIT
or not
HIT
? Academic Article
-
Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders Academic Article
-
Setting a standard for venous thromboembolism prophylaxis Academic Article
-
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial Academic Article
-
Should vitamin K be administered when HIT is diagnosed after administration of coumarin? Academic Article
-
Site-directed mutagenesis of alanine-382 of human antithrombin III Academic Article
-
Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis Academic Article
-
So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not? Academic Article
-
Soluble Ligands of the αvβ4 Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells Academic Article
-
Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia Academic Article
-
Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty Academic Article
-
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder Academic Article
-
Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis Academic Article
-
Standard assays underestimate the concentration of heparin in neonatal plasma. Academic Article
-
Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial Academic Article
-
Streptokinase Therapy in Acute Major Pulmonary Embolism: Effectiveness and Problems Academic Article
-
Streptokinase in acute major pulmonary embolism. Academic Article
-
Streptokinase in the Treatment of Major Pulmonary Embolism-Experience with Twenty-five Patients Academic Article
-
Structural Effects of a Covalent Linkage Between Antithrombin and Heparin: Covalent N-Terminus Attachment of Heparin Enhances the Maintenance of Antithrombin's Activated State Academic Article
-
Studies of the antiâplatelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens Academic Article
-
Studies of the immune response in heparin-induced thrombocytopenia Academic Article
-
Studies on the frequency of heparin-associated thrombocytopenia Academic Article
-
Studies on the medical treatment of deep vein thrombosis. Academic Article
-
Subcutaneous Heparin for Venous Thrombosis Academic Article
-
Subcutaneous compared with intravenous heparin for deep vein thrombosis. Academic Article
-
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin Academic Article
-
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial Academic Article
-
Successors to heparin: new antithrombotic agents. Academic Article
-
Superior mesenteric vein thrombosis after the Whipple procedure: an aggressive, combined treatment approach. Academic Article
-
Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis Academic Article
-
Surface modification with an antithrombin–heparin complex for anticoagulation: Studies on a model surface with gold as substrate Academic Article
-
Surgical exposure of the carotid artery for endovascular interventional procedures Academic Article
-
Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin Academic Article
-
Systematic lower limb phlebography in acute spinal cord injury in 147 patients Academic Article
-
TREATMENT OF PULMONARY EMBOLISM Academic Article
-
Temporal Aspects of Heparin-Induced Thrombocytopenia Academic Article
-
Testing for Heparin-Induced Thrombocytopenia Antibodies Academic Article
-
Testing for heparin‐induced thrombocytopenia: are we there yet? Academic Article
-
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients Academic Article
-
The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, α-thrombin Academic Article
-
The APTT Response of Pregnant Plasma to Unfractionated Heparin Academic Article
-
The Activated Partial Thromboplastin Time in the Control of Heparin Treatment Academic Article
-
The Antithrombotic Properties of Human Prothrombin Fragment 1.2 in Mice Academic Article
-
The Approach to Heparin-Induced Thrombocytopenia Academic Article
-
The Asp272–Glu282 Region of Platelet Glycoprotein Ibα Interacts with the Heparin-binding Site of α-Thrombin and Protects the Enzyme from the Heparin-catalyzed Inhibition by Antithrombin III Academic Article
-
The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells Academic Article
-
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism Academic Article
-
The Duration of Oral Anticoagulation after Deep Vein Thrombosis Academic Article
-
The Effect of Antithrombin III-Independent Thrombin Inhibitors and Heparin on Fibrin Accretion onto Fibrin-Coated Polyethylene \textbar Request PDF Academic Article
-
The Effect of Heparin Adsorbed on Sepharose-Lysine on the Inactivation of Thrombin by Anti-Thrombin III Academic Article
-
The Effect of Thrombin Inhibitors on Tissue Plasminogen Activator Induced Thrombolysis in a Rat Model Academic Article
-
The Effect of Thrombin on Platelet Accumulation on the Vessel Wall - Influence of Heparin and Aspirin Academic Article
-
The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density Academic Article
-
The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro Academic Article
-
The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction Academic Article
-
The Efficacy and Safety of Heparin in Patients With Sepsis Academic Article
-
The Emerging Role of Immunoregulation of Fibrinogen-Related Procoagulant Fgl2 in the Success or Spontaneous Abortion of Early Pregnancy in Mice and Humans Academic Article
-
The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia Academic Article
-
The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion Academic Article
-
The Molecular Pathology of Inherited Human Antithrombin III Deficiency Academic Article
-
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia Academic Article
-
The Pathophysiology of Heparin-Induced Thrombocytopenia Academic Article
-
The Role for Optical Density in Heparin-Induced Thrombocytopenia Academic Article
-
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients Academic Article
-
The activated clotting time in cardiac surgery: should Celite or kaolin be used? Academic Article
-
The anti-inflammatory effects of heparin and related compounds Academic Article
-
The assay and partial characterization of macromolecular heparin depolymerase activity in rat small intestine Academic Article
-
The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome Academic Article
-
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia Academic Article
-
The clinical management of heparin-induced thrombocytopenia. Academic Article
-
The diagnosis and prevention of post operative venous thrombosis. Academic Article
-
The direct thrombin inhibitor hirudin Academic Article
-
The disappearance of a low molecular weight heparin fraction (cy 216) differs from standard heparin in rabbits Academic Article
-
The effect of heparin on the affinity chromatography of plasminogen Demonstration of heparin-plasminogen interaction Academic Article
-
The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass Academic Article
-
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria Academic Article
-
The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications. Academic Article
-
The epitope specificity of heparin‐induced thrombocytopenia Academic Article
-
The evolving role of direct thrombin inhibitors in acute coronary syndromes. Academic Article
-
The haemorrhagic and antithrombotic effects of dermatan sulphate. Academic Article
-
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Academic Article
-
The inactivation of thrombin and plasmin by antithrombin III in the presence of Sepharose-heparin Academic Article
-
The influence of drugs upon the anticoagulant activity of heparin. Academic Article
-
The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction Academic Article
-
The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III Academic Article
-
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin Academic Article
-
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
-
The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation Academic Article
-
The paradox of heparin‐induced thrombocytopenia Academic Article
-
The pharmacokinetics and bioavailability of subcutaneously administered dihydroergotamine, heparin and the dihydroergotamine-heparin combination Academic Article
-
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines Academic Article
-
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin Academic Article
-
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits Academic Article
-
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Academic Article
-
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia Academic Article
-
The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia Academic Article
-
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Academic Article
-
The safety of percutaneous tracheostomy in patients with coagulopathy or thrombocytopenia. Academic Article
-
The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia Academic Article
-
The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome Academic Article
-
The success of salvage procedures for failing digital replants: A retrospective cohort study Academic Article
-
The temporal profile of the anti-PF4/heparin immune response Academic Article
-
The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia Academic Article
-
The unique immunological features of heparin-induced thrombocytopenia Academic Article
-
The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study Academic Article
-
The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia Academic Article
-
The uses of heparin to treat burn injury. Academic Article
-
The value of monitoring heparin therapy in the prevention of recurrence in patients with venous thromboembolic disease. Academic Article
-
The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance Academic Article
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 Academic Article
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 Academic Article
-
Think of HIT Academic Article
-
Think of HIT When Thrombosis Follows Heparin Academic Article
-
Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors Academic Article
-
Thrombin Generation during Cardiac Surgery: Is Heparin the Ideal Anticoagulant? Academic Article
-
Thrombin Regulation in Children Differs from Adults in the Absence and Presence of Heparin Academic Article
-
Thrombin and Antithrombotics Academic Article
-
Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes Academic Article
-
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival Article
-
Thrombocytopenia found uncommonly during heparin therapy Academic Article
-
Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis Academic Article
-
Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE]) Academic Article
-
Thrombocytopénie induite par l’héparine Academic Article
-
Thromboembolism in Infants and Children With Gastrointestinal Failure Receiving Long-Term Parenteral Nutrition Academic Article
-
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism Academic Article
-
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction Conference Paper
-
Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis Academic Article
-
Thrombolysis with a Combination of Small Doses of Streptokinase and Full Doses of Heparin Academic Article
-
Thrombolytic Therapy and Fatal Pulmonary Emboli Academic Article
-
Thrombolytic Therapy for Submassive Pulmonary Embolism? Academic Article
-
Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Academic Article
-
Thrombolytic therapy for the treatment of acute pulmonary embolism. Academic Article
-
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis Academic Article
-
Thromboprophylaxis for hospitalized medical patients: A Multicenter Qualitative study Academic Article
-
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin Academic Article
-
Thromboprophylaxis in medical-surgical intensive care unit patients Academic Article
-
Thromboprophylaxis in medical–surgical critically ill patients Academic Article
-
Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial Academic Article
-
Thrombosis and anticoagulation. Academic Article
-
Thrombosis and cancer: implications beyond Trousseau Academic Article
-
Thrombosis in Children Academic Article
-
Thrombotic Complications after Substitution with a FVII Concentrate Academic Article
-
Thrombotic End Point for Assessing Argatroban Therapy for Heparin-Induced Thrombocytopenia Academic Article
-
Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption. Academic Article
-
Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay Academic Article
-
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. Academic Article
-
Transient Global Amnesia as the Presenting Feature of Heparin-Induced Thrombocytopenia Academic Article
-
Transient global amnesia associated with acute heparin-induced thrombocytopenia Academic Article
-
Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism Academic Article
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia Academic Article
-
Treatment and Prevention of Heparin-Induced Thrombocytopenia Academic Article
-
Treatment and prophylaxis of venous thromboembolism during pregnancy Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of Deep-Vein Thrombosis Academic Article
-
Treatment of First Episode of Venous Thrombosis Academic Article
-
Treatment of Heparin-Induced Thrombocytopenia Academic Article
-
Treatment of Patients with Microangiopathic Haemolytic Anaemia with Heparin Academic Article
-
Treatment of Venous Thromboembolism Academic Article
-
Treatment of Venous Thromboembolism in Patients with Congenital Deficiency of Antithrombin III Academic Article
-
Treatment of bleeding complications in patients on anticoagulant therapy Academic Article
-
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Academic Article
-
Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) Academic Article
-
Treatment of venous thromboembolic disease. Academic Article
-
Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters Academic Article
-
Tritiation of commercial heparins by reaction with NaB3H4: Chemical analysis and biological properties of the product Academic Article
-
Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation and its prevention by heparin Academic Article
-
Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction Academic Article
-
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis Academic Article
-
Unfractionated heparin and placental pathology in high-risk pregnancies: Secondary analysis of a pilot randomized controlled trial Academic Article
-
Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti‐factor Xa levels Academic Article
-
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa Academic Article
-
Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis Academic Article
-
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder Academic Article
-
Update on heparin: what do we need to know? Academic Article
-
Updates in thrombosis in pediatrics: where are we after 20 years? Academic Article
-
Use of Antithrombotic Agents During Pregnancy Academic Article
-
Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes Academic Article
-
Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions Academic Article
-
Use of a Fixed Activated Partial Thromboplastin Time Ratio to Establish a Therapeutic Range for Unfractionated Heparin Academic Article
-
Use of antithrombotic agents during pregnancy. Academic Article
-
Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Academic Article
-
Use of heparin in the investigation of obscure gastrointestinal bleeding. Academic Article
-
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol Academic Article
-
Utility of Unfractionated Heparin in Transradial Cardiac Catheterization: A Systematic Review and Meta-analysis Academic Article
-
Utility of aPTT in monitoring unfractionated heparin in children Academic Article
-
VENOUS THROMBOEMBOLISM ASSOCIATED WITH GYNECOLOGIC SURGERY Academic Article
-
VTE Prophylaxis in Critically Ill Adults Academic Article
-
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
-
Vasoflux, a New Anticoagulant With a Novel Mechanism of Action Academic Article
-
Vasospasm-induced Stroke in a Varsity Athlete Secondary to Ephedrine Ingestion Academic Article
-
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia Academic Article
-
Venous thromboembolism in critical illness in a community intensive care unit Academic Article
-
Venous thromboembolism in heparin-induced thrombocytopenia Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
Venous thromboembolism: diagnosis and management of pulmonary embolism Academic Article
-
Venous thrombosis in inflammatory bowel disease Academic Article
-
Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks? Academic Article
-
Voting with your fondaparinux Academic Article
-
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis Academic Article
-
Warfarin-Induced Skin Necrosis in 2 Patients with Protein S Deficiency: Successful Reinstatement of Warfarin Therapy Academic Article
-
Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis Academic Article
-
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome Academic Article
-
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more Academic Article
-
What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Academic Article
-
When and how to use heparin prophylaxis and treatment. Academic Article
-
When is HIT Really HIT? Academic Article
-
Which antithrombotic to use during PCI? Academic Article
-
Who Is (Still) Getting HIT? Academic Article
-
Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass Academic Article
-
Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review Academic Article
-
Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial Academic Article
-
Zinc: An important cofactor in haemostasis and thrombosis Academic Article
-
Zn2+ Mediates High Affinity Binding of Heparin to the αC Domain of Fibrinogen Academic Article
-
[10] Archaeal histones and nucleosomes Book
-
[Anticoagulants and other drugs effective against thrombosis]. Academic Article
-
[Canadian Consensus Conference on Coronary Thrombolysis--current aspects]. Academic Article
-
[Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study]. Academic Article
-
[Prevention of deep vein thrombosis and pulmonary thromboembolism]. Academic Article
-
[Prevention of venous thrombosis in paraplegic patients. An open study of fraxiparin]. Academic Article
-
[Treatment of venous thrombo--emboli]. Academic Article
-
[Venous thromboemboli]. Academic Article